Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey

 

escrs app advert

Posters

Search Title by author or title

Visual outcome and patient satisfaction following unilateral refractive lens exchange with a multifocal intraocular lens in emmetropic presbyopic patients

Poster Details

First Author: E.Levinger ISRAEL

Co Author(s):    S. Levinger   O. Trivizki   N. Levinger   I. Barequet   G. Rabina        

Abstract Details

Purpose:

To evaluate the visual outcome and patient satisfaction after a unilateral multifocal IOL implantation in emmetropic patients with presbyopia.

Setting:

Enaim Refractive Surgery Center, Jerusalem, Israel

Methods:

A unilateral phacoemulsification with Femto-laser assisted cataract surgery (FLACS) and refractive lens exchange (RLE), followed by an implantation of a trifocal diffractive intra ocular lens (IOL) (FineVision Micro F), was performed on the non-dominant eyes of emmetropic patients with presbyopia. After 6 months of follow-up, the main outcome measures were uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), and uncorrected near visual acuity (UNVA). Secondary outcomes included spherical equivalent (SE), refraction, defocus curves, contrast sensitivity, patient questionnaire and presence of visual side effects.

Results:

A total of 26 patients, with an average age of 53.8±4 years, were included in this study. Preoperative mean UDVA was 0.13±0.04 logMAR, UIVA was 0.46±0.12 logMAR, and UNVA was 0.66±0.17 logMAR, in comparison to postoperative mean UDVA of 0.18±0.32 logMAR (p=0.32), UIVA of 0.17±0.21 logMAR (p<0.05), and UNVA of 0.02±0.10 logMAR (p<0.05). Monocular UNVA of 20/25 or better in the operated eye was achieved in 23 (88%) patients. 24 (96%) patients said they will recommend this procedure to family and friends. There were no IOL exchange was required.

Conclusions:

A unilateral RLE of the non-dominant eye with FLACS and a trifocal diffractive IOL (FineVision Micro F) implantation in emmetropic,

Financial Disclosure:

None

Back to Poster listing